B. Riley raised the firm’s price target on Imax to $30 from $27 and keeps a Buy rating on the shares ahead of the Q2 report. The analyst reduced estimates, saying the Q2 domestic industry box office missed expectations. However, post-pandemic moviegoers continue to flock to premium screens, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX: